Bridge Realization Estimate
ML model predicts what fraction of the bridge is achievable (accuracy: 60%, n=5,839)
Expected realization: 52% of modeled bridge. Strengths: Occupancy Rate, Revenue per Bed. Risks: Bed Count. Risk-adjusted uplift: $295.5M (vs $566.2M modeled).
EBITDA Bridge — 7 RCM Levers
Each bar shows the annual EBITDA impact at full run-rate. Revenue levers increase top-line; cost levers reduce operating expense; cash acceleration releases working capital. Calibrated to published research bands (Denial 12%→5% = $8-15M on $400M NPR).
Lever Detail
Each value shows its data source. SELLER = seller data room, DEFAULT = model default, BENCHMARK = P75 peer benchmark.
| Lever | Current | Target | Revenue | Cost | EBITDA | WC | Ramp |
|---|---|---|---|---|---|---|---|
| Net Collection Rate | 93.5% DEFAULT | 97.0% BENCHMARK | $161.5M | $0 | $161.5M | $0 | 18mo |
| Cost to Collect | 4.5% DEFAULT | 2.5% BENCHMARK | $0 | $153.8M | $153.8M | $0 | 12mo |
| Denial Rate Reduction | 12.0% DEFAULT | 6.5% BENCHMARK | $148.1M | $4.2M | $152.3M | $0 | 12mo |
| A/R Days Reduction | 52.00 DEFAULT | 38.00 BENCHMARK | $23.6M | $70.0M | $93.6M | $295.0M | 9mo |
| Clean Claim Rate | 88.0% DEFAULT | 96.0% BENCHMARK | $0 | $4.9M | $4.9M | $0 | 6mo |
| CDI / Case Mix Index | 135.0% DEFAULT | 142.0% BENCHMARK | $0 | $0 | $0 | $0 | 18mo |
Implementation Timing Curve
Linear ramp to full run-rate per lever. Month 0 = close date. Partners should expect 60-70% of total uplift realized by month 12.
| Lever | M0 | M3 | M6 | M9 | M12 | M18 | M24 | M36 |
|---|---|---|---|---|---|---|---|---|
| Net Collection Rate | $0 | $26.9M | $53.8M | $80.8M | $107.7M | $161.5M | $161.5M | $161.5M |
| Cost to Collect | $0 | $38.5M | $76.9M | $115.4M | $153.8M | $153.8M | $153.8M | $153.8M |
| Denial Rate Reduction | $0 | $38.1M | $76.1M | $114.2M | $152.3M | $152.3M | $152.3M | $152.3M |
| A/R Days Reduction | $0 | $31.2M | $62.4M | $93.6M | $93.6M | $93.6M | $93.6M | $93.6M |
| Clean Claim Rate | $0 | $2.5M | $4.9M | $4.9M | $4.9M | $4.9M | $4.9M | $4.9M |
| Cumulative | $0 | $137.1M | $274.2M | $408.9M | $512.3M | $566.2M | $566.2M | $566.2M |
Returns Sensitivity (IRR / MOIC)
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Green = exceeds 20% IRR hurdle. Amber = 15-20%. Red = below hurdle or loss. RCM uplift of $566.2M is added at exit.
| Entry \ Exit | 9.0x | 10.0x | 11.0x | 11.5x | 12.0x |
|---|---|---|---|---|---|
| 8.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x |
| 9.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x |
| 10.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x |
| 11.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x |
| 12.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x | -100% / 0.0x |
Covenant Headroom (at 10x Entry, 6.5x Max Leverage)
Pro forma EBITDA can decline 129% before the 6.5x covenant trips. RCM uplift reduces leverage from 99.0x to -1.9x, adding 100.9 turns of cushion.
5-Year Value Creation Waterfall
EBITDA trajectory: 3% organic growth + RCM uplift ramp (full run-rate at month 18).
| Base EBITDA | RCM Uplift | Total | Margin | |
|---|---|---|---|---|
| Entry | $-103.9M | — | $-103.9M | -1.4% |
| Year 1 | $-107.0M | +$377.4M | $270.5M | 3.5% |
| Year 2 | $-110.2M | +$566.2M | $456.0M | 5.9% |
| Year 3 | $-113.5M | +$566.2M | $452.7M | 5.9% |
| Year 4 | $-116.9M | +$566.2M | $449.3M | 5.8% |
| Year 5 | $-120.4M | +$566.2M | $445.8M | 5.8% |
Achievement Sensitivity
What if we only achieve a fraction of each lever? 50% = conservative, 75% = base management case, 100% = plan, 120% = stretch.
| Lever | 50% | 75% | 100% | 120% |
|---|---|---|---|---|
| Net Collection Rate | $80.8M | $121.1M | $161.5M | $193.8M |
| Cost to Collect | $76.9M | $115.4M | $153.8M | $184.6M |
| Denial Rate Reductio | $76.1M | $114.2M | $152.3M | $182.8M |
| A/R Days Reduction | $46.8M | $70.2M | $93.6M | $112.3M |
| Clean Claim Rate | $2.5M | $3.7M | $4.9M | $5.9M |
| Total | $283.1M | $424.6M | $566.2M | $679.4M |
Peer Context — Where This Hospital Sits
Key metrics vs 9 size-matched peers. Low percentile on margin/efficiency metrics = more room for improvement = larger bridge opportunity.
| Metric | Hospital | P25 | P50 | P75 | Percentile |
|---|---|---|---|---|---|
| Op Margin | -1.4% | -20.2% | -1.4% | 2.5% | P44 |
| Net-to-Gross | 27.4% | 13.3% | 19.7% | 25.0% | P89 |
| Occupancy | 86.7% | 63.2% | 80.0% | 83.6% | P89 |
| Rev/Bed | $2.7M | $879K | $1.6M | $2.0M | P78 |
| Exp/Bed | $2.7M | $1.1M | $1.7M | $1.9M | P78 |
Bridge Methodology
Coefficients calibrated to published research bands: denial 12%→5% = $8-15M on $400M NPR. Current metrics estimated from HCRIS public data and ML predictions. Target metrics set at P75 peer benchmarks with 60% gap closure assumption. Revenue levers use NPR × delta × avoidable share. Cost levers use claims volume × cost per reworked claim. Working capital from AR reduction is one-time cash (not included in recurring EBITDA). Returns assume 5.5x leverage, 3% organic growth, 10%/yr debt paydown.